Efficacy and safety of empagliflozin in people with type 2 diabetes during Ramadan fasting-Reference-Cited by-同舟云学术

Efficacy and safety of empagliflozin in people with type 2 diabetes during Ramadan fasting

Published:2022-11 Issue:11 Volume:16 Page:102633
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Yousuf Sanobia,Ahmedani Muhammad Yakoob^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. Impact of Ramadan diurnal intermittent fasting on hypoglycemic events in patients with type 2 diabetes: a systematic review of randomized controlled trials and observational studies;Abdelrahim;Front Endocrinol,2021

2. Surat Al-Baqarah, 2:185.

3. A prospective multi-country observational trial to compare the incidences of diabetic ketoacidosis in the month of Ramadan, the preceding month, and the following month (DKAR international);Abdelgadir;J Diabetes Metab Disord,2016

4. Diabetes and Ramadan: practical guidelines international diabetes federation (IDF) in collaboration with the diabetes and Ramadan (DAR) international alliance;Hassanein;Diabetes Res Clin Pract,2017

5. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study;Salti;Diabetes Care,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impacts of Ramadan fasting for patients with non-alcoholic fatty liver disease (NAFLD): a systematic review;Frontiers in Nutrition;2024-01-17

2. Ramadan Fasting and Diabetes (2022): The Year in Review;Journal of Diabetes and Endocrine Practice;2023-04-03